EUCTR2020-001862-12-BE进行中(未招募)1 期
Early administration of Vitamin C in patients with sepsis or septic shock inemergency departments: a multicentre, double blinded, randomizedcontrolled trial: the C-EASIE trial. - The C-EASIE trial.
niversity Hospitals Leuven, Clinical Trial Centre0 个研究点目标入组 300 人开始时间: 2021年2月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Participants eligible for inclusion in this trial must meet all of the
- •following criteria:
- •1. Patient is = 18 years old.
- •2. Patient has a 'suspected infection': this requires the combination of AB administration and body fluid cultures within the first 6 hours after ED presentation.
- •3. NEWS score = 5.
- •NEWS is based on a simple aggregate scoring system in which a score is allocated to physiological measurements, already recorded in routine practice, when patients present to the hospital. Six simple physiological parameters form the basis of the scoring system: respiration rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness or new confusion and temperature.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 150
排除标准
- •Participants eligible for this trial must not meet any of the following criteria:
- •1. Patient (=18 years old) or legally authorized representative (LAR) didn't provide informed consent. Delayed informed consent can be applied in cases where the patient is critically ill and no LAR is available
- •2. AB administration as a single dose or as a prophylactic treatment.
- •3. AB administered without an accompanying body fluid culture according to the timeframe (within 6 hours after ED presentation).
- •4. 'Do no intubate' or 'comfort measures only' status.
- •5. Failure to randomize within 6 hours.
- •6. Weight < 45 kg.
- •7. Pregnant or breastfeeding.
- •8. Allergy for Vitamin C.
- •9. Known history of oxalate nephropathy or hyperoxaluria.
- •10. Known history of glucose-6-phosphate dehydrogenase deficiency.
- •11. Known history of chronic iron overload due to iron storage and other diseases.
- •12. The patient is already on IV steroids for a reason other than septic shock.
- •13. Proven active COVID-19 infection (positive swab and/or CT scan positive for COVID).
研究者
相似试验
已完成
3 期
Effect of Vit C in severe pneumoniaIRCT20190312043030N1Tabriz University of Medical Sciences80
招募中
2 期
High dose vitamin C as an adjuvant therapy in patient with septic shockPatient with septic shockseptic shock,vitamin c,ascorbic acidTCTR20180925004Bhumibol Adulyadej Hospital Fund60
已完成
3 期
Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency DepartmentsSepsis, SevereSepsisSeptic ShockNCT04747795Universitaire Ziekenhuizen KU Leuven301
尚未招募
2 期
Vitamin C in Community Acquired Pneumonia: A pilot studyACTRN12619000256178niversity of Otago140
已完成
2 期
Investigation of the effect of intravenous vitamin C on definite patients with coronavirus pneumoniaIRCT20200516047468N1Shahid Beheshti University of Medical Sciences50
